Get in touch

Patient‑specific phantoms for safer surgery

CellaCure builds modular, multi-material 3D printing systems that turn MRI and CT scans into realistic soft-tissue models of a patient's anatomy, in days instead of months.

Get in touchSee our roadmap

Winner of the ASML Young Makers Award, TU Delft Impact Contest

A scan is a stack of slices. We print it the same way, one soft layer at a time.
  1. 1

    Scan

    Start from the MRI or CT series the hospital already has.

  2. 2

    Segment

    The organ is separated from the scan into a 3D model.

  3. 3

    Print

    Soft hydrogel is laid down layer by layer, overnight.

  4. 4

    Rehearse

    Surgeons train, and engineers test devices, on the real anatomy.

Nearly half of surgical adverse events are considered preventable

Major surgery still carries a 10–20% complication rate. Rehearsing on a model of the patient's own anatomy is one way to catch problems before the first incision, but the tools for it are slow, rigid or expensive.

TodayWith CellaCure
Silicone moulds take months to make.Multi-layer, ultra-soft phantoms in under 24 hours.
Commercial 3D printers only print rigid plastics.Calibrated on site for your lab's own hydrogels and biomaterials, with no vendor lock-in.
Proprietary systems cost more than €100k.Modular systems and consulting bundles from €5k to €80k, sized for university equipment grants.

From a validated prototype to labs across Europe

  1. Done

    MVP

    Multi-material extrusion validated; ASML Young Makers Award.

  2. Now

    Pilots

    Workflow validation with Dutch University Medical Centers.

  3. Next

    Pre-seed

    CE compliance groundwork and the first paid lab installations.

  4. Later

    Scale

    Expansion to research hubs across Benelux and DACH.

Recognised at TU Delft

ASML Young Makers Award

First place in the Ideation category of the TU Delft Impact Contest, for high-precision mechatronics with a clear route to biomedical impact.

Built in the TU Delft ecosystem

Started in TU Delft labs, with ongoing mentoring from medtech, clinical and precision-hardware experts.

The team

We are four master's students at TU Delft, three in Biomedical Engineering and one in Applied Physics. Between us we cover technical validation, clinical performance, customer research, product development and company building. We have interviewed more than 15 researchers across the Netherlands to test the idea.

  • Alexandra Spiridon

    Alexandra Spiridon

    CEO, Biomedical Engineering

  • Shri Thrisha

    Shri Thrisha

    CMO, Biomedical Engineering

  • Sandro El Wadi

    Sandro El Wadi

    CFO, Biomedical Engineering

  • Ennio d'Adamo

    Ennio d'Adamo

    CTO, Applied Physics

Talk to us about a lab pilot or an investment

Write to cellacuretechnologiesnl@gmail.com or use the form. We're based in Delft, the Netherlands.